Trial Profile
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Proof-of-Concept Study to Evaluate the Safety and Efficacy of Ramelteon Taken in Combination With Doxepin for the Treatment of Subjects With Chronic Insomnia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; Doxepin
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 07 Oct 2008 New trial record.